Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blinded, Placebo-Controlled, Prospective, Multicenter CT to Evaluate Efficacy and Safety of Subcutaneous Immunotherapy in Subjects With Rhinitis With/Without Mild to Moderate Asthma Sensitized to Olive and Grass Pollen

NCT04891237 is registered in ClinicalTrials.gov with Inmunotek S.L. as lead sponsor.

NCT NCT04891237
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04891237 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blinded, Placebo-Controlled, Prospective, Multicenter CT to Evaluate Efficacy and Safety of Subcutaneous Immunotherapy in Subjects With Rhinitis With/Without Mild to Moderate Asthma Sensitized to Olive and Grass Pollen
Lead sponsor
Inmunotek S.L.
Phase
Phase 3
Overall status
Recruiting
Start date
June 14, 2021
Completion date
January 31, 2027
Enrollment
180 (estimated)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, allergic, rhinitis, allergic, rhinoconjunctivitis